Patents Assigned to VELLA BIOSCIENCE, INC.
  • Publication number: 20230338304
    Abstract: The invention relates to compositions and methods containing hemp and/or cannabis-derived cannabidiol (CBD) for topical use in treating female sexual dysfunction induced by antidepressants, including, e.g., selective serotonin reuptake inhibitors (SSRIs), serotonin/norepinephrine reuptake inhibitors (SNRIs), and other anti-depressants.
    Type: Application
    Filed: June 16, 2023
    Publication date: October 26, 2023
    Applicant: VELLA BIOSCIENCE, INC.
    Inventors: Harin Padma-Nathan, MIchael Frid, Helen Segil, Nial Chase DeMena
  • Patent number: 11717495
    Abstract: The invention relates to compositions and methods containing hemp and/or Cannabis-derived cannabidiol (CBD) for topical use in treating female sexual dysfunction induced by antidepressants, including, e.g., selective serotonin reuptake inhibitors (SSRIs), serotonin/norepinephrine reuptake inhibitors (SNRIs), and other anti-depressants.
    Type: Grant
    Filed: February 2, 2021
    Date of Patent: August 8, 2023
    Assignee: Vella Bioscience, Inc.
    Inventors: Harin Padma-Nathan, MIchael Frid, Helen Segil, Nial Chase DeMena
  • Publication number: 20210283069
    Abstract: The invention relates to compositions and methods containing hemp and/or cannabis-derived cannabidiol (CBD) for topical use in treating female sexual dysfunction induced by antidepressants, including, e.g., selective serotonin reuptake inhibitors (SSRIs), serotonin/norepinephrine reuptake inhibitors (SNRIs), and other anti-depressants.
    Type: Application
    Filed: February 2, 2021
    Publication date: September 16, 2021
    Applicant: VELLA BIOSCIENCE, INC.
    Inventors: Harin Padma-Nathan, MIchael Frid, Helen Segil, Nial Chase DeMena